TRINORINYL Trademark
Trademark Overview
On Monday, March 8, 1982, a trademark application was filed for TRINORINYL with the United States Patent and Trademark Office. The USPTO has given the TRINORINYL trademark a serial number of 73353616. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, August 25, 1983. This trademark is owned by SYNTEX (F.P.) INC.. The TRINORINYL trademark is filed in the Pharmaceutical Products category with the following description:
HORMONE PREPARATIONS
General Information
| Serial Number | 73353616 |
| Word Mark | TRINORINYL |
| Filing Date | Monday, March 8, 1982 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, August 25, 1983 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | HORMONE PREPARATIONS |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 018 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, January 29, 1982 |
| First Use In Commerce Date | Friday, January 29, 1982 |
Trademark Owner History
| Party Name | SYNTEX (F.P.) INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | HUMACAO 00661
PR |
Trademark Events
| Event Date | Event Description |
| Thursday, August 25, 1983 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, January 20, 1983 | NON-FINAL ACTION MAILED |
| Thursday, December 9, 1982 | ASSIGNED TO EXAMINER |
